B
Bellerophon Therapeutics Inc
OTC:BLPH
Bellerophon Therapeutics Inc
OTC:BLPH
Price:
0.1025
USD
Market Closed
Market Cap:
$146.8k
Relative Value
There is not enough data to reliably calculate the relative value of BLPH.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BLPH
Relative Value
Base Case
Not Available
Multiples Across Competitors
BLPH Competitors Multiples
Bellerophon Therapeutics Inc Competitors
Bellerophon Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
B
|
Bellerophon Therapeutics Inc
OTC:BLPH
|
3.7m USD | 0.8 | -0.5 | 0 | 0 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
190.8B USD | 4.3 | 29.3 | 16.8 | 23 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
173.9B USD | 17.3 | 61 | 46.3 | 56.9 | |
| US |
|
Stryker Corp
NYSE:SYK
|
139.8B USD | 5.6 | 43 | 21.8 | 26.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
116.7B USD | 3.3 | 25.3 | 13.9 | 20.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.2B USD | 5.3 | 36.7 | 21.5 | 28.8 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
45.6B EUR | 2 | 21.6 | 11.9 | 16.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
48.5B USD | 11.3 | 45.7 | 32.5 | 35.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.7B USD | 7.9 | 44.4 | 24.4 | 26.7 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48B USD | 2.2 | 27.2 | 10.6 | 17.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.8B USD | 6.8 | 24.8 | 17.5 | 19.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
